Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2008
06/26/2008WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/26/2008WO2008075736A1 Method for producing c-glycoside derivative and synthetic intermediate thereof
06/26/2008WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors
06/26/2008WO2008075064A1 Piperidine derivatives for the treatment of obesity
06/26/2008WO2008075019A1 Modulators of cb1 receptors
06/26/2008WO2008075005A1 Quinuclidinol derivatives as muscarinic receptor antagonists
06/26/2008WO2008074997A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors
06/26/2008WO2008074835A1 2-substituted 5-membered heterocycles as scd inhibitors
06/26/2008WO2008074832A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd)
06/26/2008WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/26/2008WO2008074686A1 Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests
06/26/2008WO2008074413A2 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase
06/26/2008WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives
06/26/2008WO2006108791A3 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides
06/26/2008US20080153872 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity
06/26/2008US20080153821 Nitrogen-containing 5-membered ring compound
06/26/2008US20080153817 Treatment for Alzheimer's Disease and Related Conditions
06/26/2008US20080153799 Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators
06/26/2008US20080149097 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disordersB
06/26/2008CA2673582A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors
06/26/2008CA2673564A1 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
06/26/2008CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/26/2008CA2673177A1 Modulators of cb1 receptors
06/26/2008CA2672776A1 2-substituted 5-membered heterocycles as scd inhibitors
06/26/2008CA2672521A1 Pyrazole derivatives as protein kinase inhibitors
06/26/2008CA2671738A1 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
06/26/2008CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/25/2008EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
06/25/2008EP1935869A1 Retinoids for the treatment of emphysema
06/25/2008EP1934184A1 3 -azabicyclooctane derivatives as muscarinic receptor antagonists
06/25/2008EP1934181A2 Kinase inhibitors
06/25/2008EP1934174A1 Azetidines as mek inhibitors for the treatment of proliferative diseases
06/25/2008EP1933622A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
06/25/2008EP1730140B1 Opioid receptor antagonists
06/25/2008EP1606266A4 Chemical compounds
06/25/2008EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
06/25/2008EP1458393B1 Substituted diketopiperazines as oxytocin antagonists
06/25/2008EP0986382B1 Raf kinase inhibitors
06/25/2008CN101208334A Novel cyclic amines
06/25/2008CN101208331A Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors
06/25/2008CN101208326A Derivate von dihydroxyphenylalanin
06/25/2008CN101208302A Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors
06/25/2008CN101205227A Novel compound
06/25/2008CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/25/2008CN100396678C Synthesis and uses of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole
06/25/2008CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/25/2008CN100396675C Prodrugs of proton pump inhibitors
06/24/2008US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
06/24/2008US7390898 Cytotoxic agents containing novel potent taxanes and their therapeutic use
06/24/2008US7390820 Substituted quinolinone derivatives and methods of use
06/24/2008US7390815 Pyrazole compounds useful as protein kinase inhibitors
06/24/2008US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma
06/19/2008WO2008073461A2 Ion channel modulators
06/19/2008WO2008072596A1 Organic electroluminescent device, display and illuminating device
06/19/2008WO2008071646A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008WO2008071453A1 1,2-diarylacetylene derivatives of acyltryptophanols
06/19/2008WO2008071451A1 Dihydropyridine derivatives useful as protein kinase inhibitors
06/19/2008WO2008071405A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/19/2008WO2008071400A1 Process for the preparation of valsartan and intermediate products
06/19/2008WO2008044217A3 2-aminocarbonyl-pyridine derivatives
06/19/2008WO2008043544A8 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
06/19/2008US20080146810 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
06/19/2008US20080146808 Antiapoptosis; cancers; inhibiting the caspases;
06/19/2008US20080146797 Process for synthesizing heterocyclic compounds
06/19/2008US20080146635 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion
06/19/2008US20080146632 Fc Receptor Modulating Compounds and Compositions
06/19/2008US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain.
06/19/2008US20080146607 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents
06/19/2008US20080146599 receptor tyrosine kinase inhibitors such as 2-chloro-N-{3-[(4,6-diaminopyrimidin-5-yl)ethynyl]phenyl}benzenesulfonamide, used as angiogenesis inhibitors in mammals
06/19/2008US20080146574 Heterocycle Substituted Carboxylic Acids
06/19/2008US20080145698 Compounds For Organic Electronic Devices
06/19/2008US20080142792 Di-thieno-benzo-thieno-thiophene derivatives; heat treatment; improved solubility
06/19/2008DE102005043371B4 Thiophenderivat und seine Verwendung in einem organischen elektrolumineszierenden Element Thiophene derivative and its use in an organic electroluminescent element
06/19/2008CA2672233A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
06/19/2008CA2672167A1 Dihydropyridine derivatives as useful as protein kinase inhibitors
06/19/2008CA2672023A1 Process for the preparation of valsartan and intermediate products
06/19/2008CA2671984A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008CA2671970A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/18/2008EP1932841A1 Sulfonamide compound
06/18/2008EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
06/18/2008EP1932831A1 1,2-Diarylacetylene Derivatives of Acyltryptophanols
06/18/2008EP1931658A2 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds
06/18/2008EP1931657A2 Novel high affinity quinoline-based kinase ligands
06/18/2008EP1931651A1 Thiophene derivatives for the treatment of diabetes
06/18/2008EP1931645A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
06/18/2008EP1594861B1 Triazole compounds and the therapeutic use thereof
06/18/2008EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
06/18/2008EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
06/18/2008CN101203509A Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
06/18/2008CN101203508A Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kvl .5 potassium channel blockers and pharmaceutical preparations comprising them
06/18/2008CN101203491A Tetrahydrocarbazole derivatives used as androgen receptor modifier
06/18/2008CN100395234C Novel CB1 receptour inverse agonists
06/17/2008US7388021 Novel pyridyl or phenyl ureas and analogues; Purinoreceptors inhibitors; 1-(4-tert-butylphenyl)-3-(2-(3-isopropylphenoxy)pyridin-3-yl)urea; for the treatment of a thromboembolic disorders
06/17/2008US7388018 for controlling phytopathogenic harmful fungi;
06/17/2008US7388012 (Hydrazido)(amino)thiophene compounds
06/17/2008CA2501799C Pyrazole compounds for treatment of neurodegenerative disorders
06/17/2008CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
06/17/2008CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
06/17/2008CA2284468C Anti-inflammatory compounds
06/12/2008WO2008070661A1 Substituted pyrimidines as adenosine receptor antagonists